WallStreetZenWallStreetZen

NASDAQ: BFRI
Biofrontera Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their BFRI stock forecasts and price targets.

Forecast return on equity

Is BFRI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.83%

Forecast return on assets

Is BFRI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BFRI revenue forecast

What is BFRI's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$40.9M+20.04%
Avg 2 year Forecast
$51.7M+51.71%
Avg 3 year Forecast
$65.3M+91.69%
BFRI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BFRI revenue growth forecast

How is BFRI forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
24.22%
Industry
9.2%
Market
9.94%
BFRI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BFRI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BFRI vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
BFRI$1.59N/AN/A
UPC$2.18N/AN/A
COSM$0.65N/AN/A
CLVR$4.11N/AN/A
SHPH$0.39N/AN/A
View Top Pharmaceutical Stocks

Biofrontera Stock Forecast FAQ

What is BFRI's revenue growth forecast for 2024-2026?

(NASDAQ: BFRI) Biofrontera's forecast annual revenue growth rate of 24.22% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.2%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.94%.

Biofrontera's revenue in 2024 is $34,071,000.On average, 1 Wall Street analysts forecast BFRI's revenue for 2024 to be $208,156,992, with the lowest BFRI revenue forecast at $208,156,992, and the highest BFRI revenue forecast at $208,156,992. On average, 1 Wall Street analysts forecast BFRI's revenue for 2025 to be $263,071,758, with the lowest BFRI revenue forecast at $263,071,758, and the highest BFRI revenue forecast at $263,071,758.

In 2026, BFRI is forecast to generate $332,389,563 in revenue, with the lowest revenue forecast at $332,389,563 and the highest revenue forecast at $332,389,563.

If you're new to stock investing, here's how to buy Biofrontera stock.

What is BFRI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BFRI) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is BFRI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BFRI) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.